Evidence map›Paper›PMID 25620850›Full record

ArticleNihon Masu Sukuriningu Gakkai shi = Journal of Japanese Society for Mass-Screening

Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry.

Shunji Tomatsu, Francyne Kubaski, Kazuki Sawamoto, Robert W Mason, Eriko Yasuda, Tsutomu Shimada, Adriana M Montaño, Seiji Yamaguchi, Yasuyuki Suzuki, Tadao Orii

Open access · greenAbstract read
In one paragraph

Article in Nihon Masu Sukuriningu Gakkai shi = Journal of Japanese Society for Mass-Screening. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Detection of Glycosaminoglycans in Biological Specimens.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Advances in glycosaminoglycan detection.Molecular genetics and metabolism · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Shunji TomatsuNemours/Alfred I. duPont Hospital for Children, Wilmington, DE ; Department of Pediatrics, Gifu University, Gifu, Japan.
Francyne KubaskiNemours/Alfred I. duPont Hospital for Children, Wilmington, DE ; Department of Biological Sciences, University of Delaware, Newark, DE.
Kazuki SawamotoNemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Robert W MasonNemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Eriko YasudaNemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Tsutomu ShimadaNemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Adriana M MontañoDepartment of Pediatrics, Saint Louis University, St. Louis, Missouri, USA.
Seiji YamaguchiDepartment of Pediatrics, Shimane University, Izumo, Japan.
Yasuyuki SuzukiMedical Education Development Center, Gifu University.
Tadao OriiDepartment of Pediatrics, Gifu University, Gifu, Japan.
Alfred I. duPont Hospital for Children · USEducation Development Center · USGifu University · JPSaint Louis University · USShimane University · JP

Funding

Center for Pediatric ResearchP20GM103464 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI SHAFFER, THOMAS H · 2012 to 2014
$5.6M
Newborn Screening and Biomarkers for MucopolysaccharidosesR01HD065767 · NICHD · SAINT LOUIS UNIVERSITY · PI MONTANO, ADRIANA MARIA, TOMATSU, SHUNJI · 2011 to 2015
$2.4M
NICHD NIH HHS R01 HD065767NIGMS NIH HHS P20 GM103464
6 · The paper itself

Abstract

Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by the deficiency of lysosomal enzymes. The enzymes are required to break down glycosaminoglycans (GAGs) that help build bone, cartilage, tendons, corneas, skin and connective tissue. In patients with MPS, a missing enzyme leads to the accumulation of GAGs in the cells, blood, connective tissues, and multiple organs. The consequence is permanent, with progressive cellular damage affecting patients' appearance, physical abilities, organ and system function, and skeletal and mental development. The measurement of each specific GAG in a variety of specimens is required to establish the correlation between GAGs and physiological status of patients and/or prognosis and pathogenesis of the disease and to separate the patients with MPS from the healthy controls. We have developed a highly accurate, sensitive, and cost-effective liquid chromatography tandem mass spectrometry (LC-MS/MS) method for measurements of disaccharides derived from four specific GAGs [chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS)]. Disaccharides were produced by specific enzyme digestion of each GAG, and subsequently, quantified by negative ion mode of multiple reaction monitoring. Subclasses of GAGs with the same molecular weights can be separated by liquid chromatography. We have also developed another GAG assay by high-throughput mass spectrometry (HT-MS/MS). The HT-MS/MS consists of an integrated solid phase extraction robot that binds and de-salts samples from assay plates and directly injects them into a MS/MS detector, reducing sample processing time to within ten seconds. HT-MS/MS consequently yields much faster throughput than conventional LC-MS/MS-based methods; however, the HT-MS/MS system does not use a chromatographic step, and therefore, cannot separate GAGs that have the same molecular weights. Both techniques can be applied to the analysis of dried blood spots, blood, and urine specimens. In this review, we describe the assay methods for GAGs and the application to newborn screening and diagnosis of MPS.

Indexed as

diagnosisglycosaminoglycansmucopolysaccharidosesnewborn screeningtandem mass spectrometry

Identifiers

PMID25620850
PMCPMC4303184
OpenAlexW124407421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.